At nearly 73, Dawn Zuidgeest-Craft embarks on a medical residency, challenging age norms in the field. She reflects on her journey and the dedication required to become a physician.
The Trump administration has announced measures aimed at addressing a loophole in Medicare drug price negotiations, which could affect costs for beneficiaries and pharmaceutical companies.
In an unusual initiative, Blood Cancer United, a nonprofit organization, is acquiring the last supplies of an investigational cancer drug that has been discontinued.
Recent findings from Chile highlight the impact of food warning labels on public health, as part of ongoing discussions on nutritional awareness.
During a recent finance conference, hospital executives acknowledged the pressing issue of affordability in healthcare, though solutions remain uncertain.
Recent developments in cryo-electron microscopy techniques enable the observation of materials in organic solvents, potentially transforming the study of various advanced technologies.
An ongoing evaluation of Robert F. Kennedy Jr.'s Make America Healthy Again initiative reveals a mix of achievements and unmet objectives.
The landscape of obesity medications is evolving, with new drugs entering the market and peptides gaining traction in treatment protocols. The FDA's decisions will be pivotal.
Recent findings from the CDC reveal a troubling trend: drinking during pregnancy has increased since 2020, raising concerns about maternal and fetal health.
This editorial explores the executive orders and actions taken by the Trump Administration since January 21, 2025, that influence U.S. global health initiatives.
In recent biotech developments, Novartis has reaffirmed its focus on molecular glue strategies amidst rising drug costs for seniors and advancements in leukemia treatments.
The dynamics of competition among Medicare Part D plans are increasingly affected by the payment structure of Medicare Advantage plans, raising concerns about fairness.
Recent developments, including a federal memo on alleged vaccine-related deaths and the establishment of a detransition clinic, illustrate how rare outcomes can shape public views on vaccine safety and gender care.
Elizabeth Selvin reflects on the stark contrast in publication fees at Nature Medicine between 2025 and 2026, highlighting a significant financial burden for researchers.
A recent study by researchers at Skoltech, in collaboration with teams from the U.S. and China, sheds light on how anti-CRISPR proteins contribute to the spread of antibiotic resistance in Klebsiella pneumoniae.
The House Appropriations Committee has unveiled the FY 2027 appropriations bill for Labor, Health and Human Services, Education, and related agencies, highlighting global health funding.
A recent analysis highlights a troubling increase in drug shortages and pricing pressures in Europe, with U.S. authorities intensifying their scrutiny.
The Department of Justice has announced a second settlement concerning youth gender care, amidst broader health news including updates on sunscreen and leadership at NIAID.
As the U.S. observes the situation, European countries are developing varied approaches to drug pricing, which could have significant implications for the pharmaceutical sector and patient access.
This editorial examines how health care systems may affect native populations' views on immigration, particularly in light of rising anti-immigration sentiments globally.